Rumalon solution 1ml ampoules, 10pcs

Composition

Solution for intramuscular use.

1 amp. contains glycosaminoglycan-peptide complex 1 ml

Pharmacological action

Pharmacodynamics

Combined preparation of animal origin, contains a glycosaminoglycan-peptide complex. The effect of the drug is due to the combined effect of its active components.

Normalizes the metabolism in cartilage hyaline tissue: enhances the biosynthesis of sulfated mucopolysaccharides and collagen, stimulates the regeneration of articular cartilage, reduces the activity of enzymes and inhibits catabolic processes in cartilage tissue.

Pharmacokinetics

No studies were conducted.

Indications

Degenerative-dystrophic diseases of the joints: gonarthrosis, arthrosis of the interdigital joints, coxarthrosis, spondylosis, spondyloarthrosis, meniscopathy, patellar chondromalacia.

Contraindications

-hypersensitivity to the components of the drug,

– rheumatoid arthritis,

– age up to 18 years,

– pregnancy, breastfeeding,

– use in women of reproductive age who do not follow reliable methods of contraception.

Side effects

According to WHO, undesirable effects are classified according to their frequency as follows: very common (≥1/10), common (≥1/100 to.

From the immune system:

Rare: allergic reactions, including anaphylactoid reactions, anaphylactic shock.

If you experience side effects that are not described in these instructions, you should stop taking the drug and inform your doctor about this.

Interaction

Rumalon® can be used simultaneously with nonsteroidal anti-inflammatory drugs and glucocorticosteroids.

When used concomitantly with indirect anticoagulants, antiplatelet agents and fibrinolytics, their effect may be enhanced.

How to take, course of use and dosage

The drug is administered deep intramuscularly: on the first day — 0.3 ml, on the second day — 0.5 ml and then 3 times a week for 1 ml for 5-6 weeks.

Repeat the course of treatment – after consulting a doctor according to the same scheme.

Special instructions

When used concomitantly with indirect anticoagulants, antiplatelet agents and fibrinolytics, frequent monitoring of blood clotting parameters is necessary.

The use of the drug does not affect the ability to perform potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, working as a dispatcher and operator).

Storage conditions

At a temperature not exceeding 25 °C in a place protected from light. Keep out of reach of children.

Shelf

life is 5 years.

Active ingredient

Glycosaminoglycan-Peptide Complex

Conditions of release from pharmacies

By prescription

Dosage form

solution for injection